Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Increased Adoption of Point-of-care Testing and Continuous Technological Advancements in Devices offer Impetus to Urinalysis Market

Article Description

Urinalysis consists of a set of analytical tests conducted on urine to screen and diagnose various conditions such as urinary tract infections, kidney disorders, liver infections, and diabetes. The test encompasses a range of microscopic, chemical, and physical examinations to detect the presence of cells, cell fragments, casts, and crystals. The test plays a vital role in the diagnosis of various chronic and age-related diseases as well as monitoring of health conditions. Urinalysis can also be done as pre-surgery preparation or for pregnancy check-up, and usually requires follow-up investigations with clinicians.

The increased adoption of point-of-care testing and ceaseless technological advancements in devices, particularly automation, are the factors stimulating the demand for various urinalysis instruments and consumables along the forecast period. According to a research report by Transparency Market Research, the global urinalysis market is projected to expand steadily with a CAGR of 5.4% during 2016-2024; the market was valued at US$929.9 mn in 2015 and is expected to reach US$1.5 bn by 2024.

Convenience of POC Urinalysis Testing in Diagnosing Diseases to Boost Market Growth

The increasing incidence of different infectious and age-associated diseases has led to a wide demand for advanced urinalysis devices and consumables-both across point-of-care and laboratory-based settings. Furthermore, the accelerated adoption rate of urinalysis to diagnose various metabolic disorders, particularly diabetes and kidney disorders, have spurred the growth of the market across major regions.

The adoption of point-of-care (POC) urinalysis testing for diabetes has emerged as a key trend accentuating market growth. Some POC tests are widely performed with technologies based on dipsticks or strips. According to the International Diabetes Federation (IDF), 5.0 million deaths were reported in 2015 and 3.2 million suffered from end-stage renal disease (ESRD). Furthermore, owing to lifestyle choices, this number is anticipated to rise dramatically-one in 10 adults is estimated to have diabetes by 2040. Advancements in technology and perpetual improvements in medical care systems have upped the demand for urinalysis in general.

Technology Advancements Resulting in Novel Instruments and Consumables Widen Scope of Urinalysis Market

A large base of the target population suffering from conditions such as kidney disorders, liver problems, and diabetes has catapulted the demand for novel urinalysis instruments and advanced consumables. Coupled with this, relentless efforts by device manufacturers to adopt automation in technologies have led to the design of next-generation analyzers that are portable and have advanced functionalities. For instance, the launch of automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray), automated microscopic urine analyzers (UF-1000i from Sysmex), and portable biochemical urine analyzers are advanced offerings by key market players that have stirred the competitive landscape.

Asia Pacific to Offer Exciting Growth Opportunities

Asia Pacific is anticipated to create ample growth opportunities for manufacturers and vendors in the urinalysis market. The developments will be driven by a growing pool of ageing population, a number of laboratory diagnosis tests for various metabolic diseases, and popularity of point-of-care testing. Furthermore, improvements in healthcare infrastructure in countries such as India, China, and Japan along with enhanced accuracy of urinalysis in the detection of urinary tract infection are the factors offering momentum to the market.

Browse the full Global Urinalysis Market report

All these developments will enhance clinical outcomes in the treatment of a range of metabolic disorders. Furthermore, various healthcare industry experts are optimistic that in the not-so-distant-future, urinalysis may become the preferred option for detecting cancer and other diseases caused by genes.